Alere Gets FDA Clearance for Molecular Flu A/B Test | GenomeWeb

NEW YORK (GenomeWeb) — Alere said today that it has received US Food and Drug Administration Clearance for the Alere i Influenza A&B test.

According to Alere, the new assay is the only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes. The test uses Alere's proprietary "Molecular. In Minutes" (MIM) isothermal nucleic acid amplification technology, which unlike PCR does not require thermal cycling or DNA purification, thus reducing time to result.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.